Incannex Healthcare Limited (IXHL)

NASDAQ

$3,01

$+0,04

(+1,49%)

Pre-Market

Incannex Healthcare Limited (IXHL) Live Price Chart

Last updated: ⁦2026-10-13 12:29:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Incannex Healthcare Limited (IXHL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3,01, with a market capitalisation of $38,89M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,49 to $14,91. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$38,89M
Open	$2,96
Day's High	$2.700,00
Day's Low	$2,40
Previous Close	$2,90
Volume	322,00
Average Volume	91,51K
P/E Ratio	--
52-Week High	$14,91
52-Week Low	$2,49
Dividend Yield	--
Earnings Date	--

Incannex Healthcare Limited (IXHL) Pre-Market Stock Price

Incannex Healthcare Limited (IXHL) is trading at $3,01 in pre-market trading as of 2026-10-13 12:27:00, up 3,62% ($0,10) from the previous close of $2,90

Pre-market trading shows how investors are pricing IXHL before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Incannex Healthcare Limited (IXHL) 7-Day Stock Price Change

Over the past seven days, Incannex Healthcare Limited (IXHL) moved from $3,21 to $3,01, representing a decline of 6,39% ($0,21).

The stock traded between $2,85 and $3,33 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 60,27 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

IXHL 52-Week Price Position

Position in Range: 4,1%

52W Low$2,49

52W High$14,91

IXHL is currently trading at $3,01, placing it 4,1% of the way from its 52-week low of $2,49 to its 52-week high of $14,91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Incannex Healthcare Limited (IXHL)?

Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.

Incannex Healthcare Limited Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	12
Exchange	NASDAQ
Company Website	https://www.incannex.com.au

How to Buy Incannex Healthcare Limited (IXHL) Stock on MEXC

Eligible investors can buy real shares of Incannex Healthcare Limited (IXHL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IXHL and Place Your Order

Open the RealStocks trading page and search for IXHL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Incannex Healthcare Limited (IXHL) stock price today?

Incannex Healthcare Limited (IXHL) is currently trading at $ 3,01, up 3,62% ($0,10) from the previous close of $ 2,90. Intraday prices update in real time during regular trading hours.

2.Is IXHL stock going up or down today?

As of 2026-10-13 12:27:00, IXHL is trading at $ 3,01, up 3,62% ($0,10) from its previous close of $ 2,90. The stock has traded between $ 2,40 and $ 2.700,00 during today’s regular session. Past price movements do not guarantee future results.

3.What is IXHL pre-market price?

As of 2026-10-13 12:27:00, IXHL is trading at $ 3,01 in pre-market trading, up 3,62% ($0,10) from the previous close of $ 2,90. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IXHL after-hours price?

As of 2026-10-13 12:27:00, IXHL is trading at $ 2,96 in after-hours trading, up 2,03% ($0,06) from the regular-session close of $ 2,90. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IXHL stock trading now?

IXHL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IXHL sit relative to its 52-week high and low?

Over the past 52 weeks, IXHL has traded between a low of $ 2,49 and a high of $ 14,91. At $ 3,01, the stock is positioned 4,1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Incannex Healthcare Limited in?

Incannex Healthcare Limited (IXHL) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Incannex Healthcare Limited's market capitalisation and where is it listed?

Incannex Healthcare Limited is listed on the NASDAQ exchange with a market capitalisation of $ 38,89M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IXHL valued in terms of P/E ratio and EPS?

IXHL trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Incannex Healthcare Limited pay a dividend?

Incannex Healthcare Limited pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.